The calculation and projection of the Atherectomy Devices Market Size are critical metrics that underscore the immense commercial opportunity within the cardiovascular device sector. Recent market analyses consistently report the global market valuation in the range of USD 1.0 to 1.5 billion in the base year, with projections indicating a robust compound annual growth rate (CAGR) of around 6.5% to 8.5% over the next ten years. This growth is set to propel the market size to a valuation potentially exceeding USD 2.5 billion by the end of the forecast period. This significant expansion is a direct consequence of the increasing global incidence of target diseases—PAD and CAD—which create a perpetually growing patient population in need of treatment. Furthermore, the high average selling price (ASP) of atherectomy systems, which require substantial initial capital investment and recurrent single-use catheter costs, contributes significantly to the overall market revenue.

The market size is heavily influenced by the adoption rates of the four main product types—directional, rotational, orbital, and laser atherectomy. While Directional Atherectomy typically holds the largest revenue share, all segments contribute substantially to the total Atherectomy Devices Market Size. The peripheral vascular disease application, owing to its high patient volume and the necessity of interventions in complex lesions, accounts for the majority of the market's total revenue. Geographically, North America represents the largest contributor to the market size, benefitting from advanced healthcare infrastructure and favorable reimbursement policies. The consistent, double-digit growth forecasts in key segments confirm the enduring market viability and the compelling investment opportunity for device manufacturers and healthcare providers globally, particularly as the demand for minimally invasive interventions continues to rise.